scope:

AJMedP-7 is the primary Allied CBRN medical support doctrine and has been developed to provide the framework for the medical aspects of CBRN defence. This publication is applicable to entire NATO Command Structure (NCS) and NATO Force Structure (NFS) and supports NATO operations independent of the CBRN threat.

This document provides a list of CBRN-specific medical planning considerations to supplement existing planning guidance and Allied doctrine. It also describes the planning considerations and capabilities for medical support on any mission where medical services may provide the earliest recognition of CBRN use and the mitigation of its effects (e.g., low-threat missions). However, CBRN operational-level medical support planning is described in detail in AMedP-7.6, Commander's Guide on Medical Support to Chemical, Biological, Radiological, and Nuclear (CBRN) Defensive Operations.

Subordinate to AJMedP-7, the AMedP-7 series is intended to provide greater detail on the different aspects of joint CBRN medical support, including support to a broad population at risk (PAR). Each AMedP is written to target a specific audience or discipline.

AJMedP-7 and the AMedP-7 series also contribute to counter-terrorism operations supporting the NATO Defence Against Terrorism (DAT) Programme and Civil-Military Cooperation (CIMIC), including CBRN mass casualty (MASCAL) preparedness and management.